 REHOVOT, Israel, Aug. 19, 2021 PRNewswire -- CollPlant Nasdaq: CLGN, a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, announced the appointment of Alisa Lask to its Board of Directors. Ms. Lask is based in the United States and has held leadership roles in medical aesthetics at both Galderma and Allergan. 